Comments
Loading...
DaVita Analyst Ratings and Price Targets | NYSE:DVA | Benzinga
DaVita Inc has a consensus price target of $138.89 based on the ratings of 9 analysts. The high is $175 issued by Truist Securities on October 7, 2024. The low is $90 issued by Cowen & Co. on February 23, 2023. The 3 most-recent analyst ratings were released by Barclays, Barclays, and Truist Securities on February 18, 2025, October 31, 2024, and October 7, 2024, respectively. With an average price target of $169.33 between Barclays, Barclays, and Truist Securities, there's an implied 12.33% upside for DaVita Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Barclays
Truist Securities
UBS
B of A Securities
TD Cowen
1calculated from analyst ratings
Analyst Ratings for DaVita
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 02/18/2025 | Buy Now | 12.11% | Barclays | Andrew Mok55% | $164 → $169 | Maintains | Equal-Weight | Get Alert |
| 10/31/2024 | Buy Now | 8.8% | Barclays | Andrew Mok55% | $150 → $164 | Maintains | Equal-Weight | Get Alert |
| 10/07/2024 | Buy Now | 16.09% | Truist Securities | David Macdonald67% | $165 → $175 | Maintains | Hold | Get Alert |
| 08/20/2024 | Buy Now | 9.46% | Truist Securities | David Macdonald67% | $150 → $165 | Maintains | Hold | Get Alert |
| 08/08/2024 | Buy Now | 16.09% | UBS | Andrew Mok55% | $169 → $175 | Maintains | Buy | Get Alert |
| 08/07/2024 | Buy Now | -3.81% | B of A Securities | Kevin Fischbeck67% | $139 → $145 | Maintains | Underperform | Get Alert |
| 07/24/2024 | Buy Now | -0.49% | TD Cowen | Gary Taylor59% | $139 → $150 | Maintains | Hold | Get Alert |
| 05/15/2024 | Buy Now | -0.49% | Truist Securities | David Macdonald67% | $135 → $150 | Maintains | Hold | Get Alert |
| 05/06/2024 | Buy Now | -0.49% | Barclays | Andrew Mok55% | $133 → $150 | Maintains | Equal-Weight | Get Alert |
| 03/06/2024 | Buy Now | -11.77% | Barclays | Sarah James51% | → $133 | Initiates | → Equal-Weight | Get Alert |
| 02/20/2024 | Buy Now | -10.44% | Truist Securities | David Macdonald67% | $130 → $135 | Maintains | Hold | Get Alert |
| 02/15/2024 | Buy Now | -3.81% | UBS | Andrew Mok55% | $134 → $145 | Maintains | Buy | Get Alert |
| 02/14/2024 | Buy Now | -11.11% | UBS | Andrew Mok55% | $113 → $134 | Maintains | Buy | Get Alert |
| 02/14/2024 | Buy Now | -13.76% | Truist Securities | David Macdonald67% | $120 → $130 | Maintains | Hold | Get Alert |
| 11/17/2023 | Buy Now | -25.04% | UBS | Andrew Mok55% | $142 → $113 | Maintains | Buy | Get Alert |
| 10/11/2023 | Buy Now | -31.01% | Truist Securities | David Macdonald67% | $115 → $104 | Maintains | Hold | Get Alert |
| 08/07/2023 | Buy Now | -5.8% | UBS | Andrew Mok55% | $100 → $142 | Upgrade | Neutral → Buy | Get Alert |
| 07/13/2023 | Buy Now | -23.71% | Truist Securities | David Macdonald67% | $100 → $115 | Maintains | Hold | Get Alert |
| 05/15/2023 | Buy Now | -33.66% | Bernstein | Lisa Bedell Clive37% | $88 → $100 | Maintains | Market Perform | Get Alert |
| 05/09/2023 | Buy Now | -25.04% | Deutsche Bank | Pito Chickering67% | $85 → $113 | Maintains | Hold | Get Alert |
| 05/09/2023 | Buy Now | -33.66% | Truist Securities | David Macdonald67% | $90 → $100 | Maintains | Hold | Get Alert |
| 05/09/2023 | Buy Now | -34.99% | TD Cowen | Gary Taylor59% | $90 → $98 | Maintains | Market Perform | Get Alert |
| 05/09/2023 | Buy Now | -36.31% | B of A Securities | Kevin Fischbeck67% | $86 → $96 | Maintains | Underperform | Get Alert |
| 03/07/2023 | Buy Now | — | Bernstein | Lisa Bedell Clive37% | — | Reinstates | → Market Perform | Get Alert |
| 02/23/2023 | Buy Now | -40.29% | Cowen & Co. | Gary Taylor59% | $76 → $90 | Maintains | Outperform | Get Alert |
| 02/23/2023 | Buy Now | -40.29% | Truist Securities | David Macdonald67% | $84 → $90 | Maintains | Hold | Get Alert |
| 10/31/2022 | Buy Now | -50.25% | Truist Securities | David Macdonald67% | $90 → $75 | Maintains | Hold | Get Alert |
| 10/31/2022 | Buy Now | -46.27% | Barclays | Sarah James51% | $103 → $81 | Maintains | Equal-Weight | Get Alert |
| 10/31/2022 | Buy Now | -50.91% | UBS | Andrew Mok55% | $117 → $74 | Downgrade | Buy → Neutral | Get Alert |
| 08/19/2022 | Buy Now | -22.38% | UBS | Andrew Mok55% | $106 → $117 | Upgrade | Neutral → Buy | Get Alert |
| 08/04/2022 | Buy Now | -31.67% | Barclays | Sarah James51% | $128 → $103 | Maintains | Equal-Weight | Get Alert |
| 08/02/2022 | Buy Now | -35.65% | Deutsche Bank | Pito Chickering67% | $150 → $97 | Maintains | Buy | Get Alert |
| 06/22/2022 | Buy Now | -40.29% | Truist Securities | David Macdonald67% | $110 → $90 | Maintains | Hold | Get Alert |
FAQ
What is the target price for DaVita (DVA) stock?
The latest price target for DaVita (NYSE:DVA) was reported by Barclays on February 18, 2025. The analyst firm set a price target for $169.00 expecting DVA to rise to within 12 months (a possible 12.11% upside). 9 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for DaVita (DVA)?
The latest analyst rating for DaVita (NYSE:DVA) was provided by Barclays, and DaVita maintained their equal-weight rating.
When was the last upgrade for DaVita (DVA)?
The last upgrade for DaVita Inc happened on August 7, 2023 when UBS raised their price target to $142. UBS previously had a neutral for DaVita Inc.
When was the last downgrade for DaVita (DVA)?
The last downgrade for DaVita Inc happened on October 31, 2022 when UBS changed their price target from $117 to $74 for DaVita Inc.
When is the next analyst rating going to be posted or updated for DaVita (DVA)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of DaVita, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for DaVita was filed on February 18, 2025 so you should expect the next rating to be made available sometime around February 18, 2026.
Is the Analyst Rating DaVita (DVA) correct?
While ratings are subjective and will change, the latest DaVita (DVA) rating was a maintained with a price target of $164.00 to $169.00. The current price DaVita (DVA) is trading at is $150.74, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.